Uterine dysfunction in biglycan and decorin deficient mice leads to dystocia during parturition

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wu, Zhiping ^a   Aron, Abraham W ^a   Macksoud, Elyse E ^a   Iozzo, Renato V ^b   Hai, Chi Ming ^a   Lechner, Beatrice E ^a  

^a BROWN UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; DECORIN; LEUCINE; OXYTOCIN; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CONTROLLED STUDY; DYSTOCIA; EHLERS DANLOS SYNDROME; EXTRACELLULAR MATRIX; FEMALE; GENE MUTATION; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LABOR ONSET; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX DISEASE; UTERUS CONTRACTION; UTERUS RUPTURE; WILD TYPE; ALLELE; ANIMAL; BIOMECHANICS; C3H MOUSE; DRUG EFFECT; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; UTERUS;

MUS;

ALLELES; ANIMALS; BIGLYCAN; BIOMECHANICS; DECORIN; DYSTOCIA; FEMALE; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; OXYTOCIN; PARTURITION; PREGNANCY; TRANSFORMING GROWTH FACTOR BETA; UTERINE CONTRACTION; UTERUS;

EID: 84855862394     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029627     Document Type: Article

References (47)

1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Mathews TJ, et al. (2010) Births: final data for 2007. Natl Vital Stat Rep 58: 1-85.
2. Choudhury AP, Dawson AJ, (2009) Trends in indications for caesarean sections over 7 years in a Welsh district general hospital. J Obstet Gynaecol 29: 714-717.
3. Wray S, (1993) Uterine contraction and physiological mechanisms of modulation. Am J Physiol 264: C1-18.
4. Main DM, Main EK, Moore DH 2nd, (2000) The relationship between maternal age and uterine dysfunction: a continuous effect throughout reproductive life. Am J Obstet Gynecol 182: 1312-1320.
5. Lowe NK, Corwin EJ, (2011) Proposed biological linkages between obesity, stress, and inefficient uterine contractility during labor in humans. Med Hypotheses 76: 755-760.
6. Siggs OM, Schnabl B, Webb B, Beutler B, (2011) X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C. Proc Natl Acad Sci U S A 108: 7890-7895.
7. Pierce SL, Kresowik JD, Lamping KG, England SK, (2008) Overexpression of SK3 channels dampens uterine contractility to prevent preterm labor in mice. Biol Reprod 78: 1058-1063.
8. Kimura T, Ogita K, Kusui C, Ohashi K, Azuma C, et al. (1999) What knockout mice can tell us about parturition. Rev Reprod 4: 73-80.
9. Wadhwa S, Embree MC, Bi Y, Young MF, (2004) Regulation, regulatory activities, and function of biglycan. Crit Rev Eukaryot Gene Expr 14: 301-315.
10. Young MF, Bi Y, Ameye L, Chen XD, (2002) Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 19: 257-262.
11. Melchior-Becker A, Dai G, Ding Z, Schafer L, Schrader J, et al. (2011) Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem 286: 17365-17375.
12. Bowe MA, Mendis DB, Fallon JR, (2000) The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J Cell Biol 148: 801-810.
13. Wiberg C, Hedbom E, Khairullina A, Lamande SR, Oldberg A, et al. (2001) Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem 276: 18947-18952.
14. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, et al. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302 (Pt 2): 527-534.
15. Wiberg C, Klatt AR, Wagener R, Paulsson M, Bateman JF, et al. (2003) Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J Biol Chem 278: 37698-37704.
16. Hayashi Y, Liu CY, Jester JJ, Hayashi M, Wang IJ, et al. (2005) Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. Dev Biol 277: 222-234.
17. Chen XD, Fisher LW, Robey PG, Young MF, (2004) The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. Faseb J 18: 948-958.
18. Moreno M, Munoz R, Aroca F, Labarca M, Brandan E, et al. (2005) Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. Embo J 24: 1397-1405.
19. Iozzo RV, Murdoch AD, (1996) Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 10: 598-614.
20. Iozzo RV, Schaefer L, (2010) Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J.
21. Keene DR, San Antonio JD, Mayne R, McQuillan DJ, Sarris G, et al. (2000) Decorin binds near the C terminus of type I collagen. J Biol Chem 275: 21801-21804.
22. Chen CP, Chang SC, Vivian Yang WC, (2007) High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 28: 97-106.
23. Meinert M, Eriksen GV, Petersen AC, Helmig RB, Laurent C, et al. (2001) Proteoglycans and hyaluronan in human fetal membranes. Am J Obstet Gynecol 184: 679-685.
24. Gogiel T, Jaworski S, (2000) Proteoglycans of human umbilical cord arteries. Acta Biochim Pol 47: 1081-1091.
25. Gogiel T, Bankowski E, Jaworski S, (2003) Proteoglycans of Wharton's jelly. Int J Biochem Cell Biol 35: 1461-1469.
26. Valiyaveettil M, Achur RN, Muthusamy A, Gowda DC, (2004) Characterization of chondroitin sulfate and dermatan sulfate proteoglycans of extracellular matrices of human umbilical cord blood vessels and Wharton's jelly. Glycoconj J 21: 361-375.
27. San Martin S, Soto-Suazo M, De Oliveira SF, Aplin JD, Abrahamsohn P, et al. (2003) Small leucine-rich proteoglycans (SLRPs) in uterine tissues during pregnancy in mice. Reproduction 125: 585-595.
28. San Martin S, Zorn TM, (2003) The small proteoglycan biglycan is associated with thick collagen fibrils in the mouse decidua. Cell Mol Biol (Noisy-le-grand) 49: 673-678.
29. Hjelm AM, Barchan K, Malmstrom A, Ekman-Ordeberg GE, (2002) Changes of the uterine proteoglycan distribution at term pregnancy and during labour. Eur J Obstet Gynecol Reprod Biol 100: 146-151.
30. Corsi A, Xu T, Chen XD, Boyde A, Liang J, et al. (2002) Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17: 1180-1189.
31. Kresse H, Rosthoj S, Quentin E, Hollmann J, Glossl J, et al. (1987) Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid. Am J Hum Genet 41: 436-453.
32. Quentin E, Gladen A, Roden L, Kresse H, (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci U S A 87: 1342-1346.
33. Lind J, Wallenburg HC, (2002) Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand 81: 293-300.
34. Erez Y, Ezra Y, Rojansky N, (2008) Ehlers-Danlos type IV in pregnancy. A case report and a literature review. Fetal Diagn Ther 23: 7-9.
35. Ploeckinger B, Ulm MR, Chalubinski K, (1997) Ehlers-Danlos syndrome type II in pregnancy. Am J Perinatol 14: 99-101.
36. Roop KA, Brost BC, (1999) Abnormal presentation in labor and fetal growth of affected infants with type III Ehlers-Danlos syndrome. Am J Obstet Gynecol 181: 752-753.
37. Lechner BE, Lim JH, Mercado ML, Fallon JR, (2006) Developmental regulation of biglycan expression in muscle and tendon. Muscle Nerve 34: 347-355.
38. Mercado ML, Amenta AR, Hagiwara H, Rafii MS, Lechner BE, et al. (2006) Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. Faseb J 20: 1724-1726.
39. Sanches JC, Jones CJ, Aplin JD, Iozzo RV, Zorn TM, et al. Collagen fibril organization in the pregnant endometrium of decorin-deficient mice. J Anat 216: 144-155.
40. Calmus ML, Macksoud EE, Tucker R, Iozzo RV, Lechner BE, (2011) A Mouse Model of Spontaneous Preterm Birth Based on the Genetic Ablation of Biglycan and Decorin. Reproduction.
41. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, et al. (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20: 78-82.
42. Fonseca V, Avizinis J, Moon-Massat P, Freilich D, Kim HW, et al. (2010) Differential sensitivities of pulmonary and coronary arteries to hemoglobin-based oxygen carriers and nitrovasodilators: study in a bovine ex vivo model of vascular strips. Vascul Pharmacol 52: 215-223.
43. Biswas B, Adhya S, Washart P, Paul B, Trostel AN, et al. (2002) Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 70: 204-210.
44. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, et al. (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136: 729-743.
45. Ameye L, Young MF, (2002) Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12: 107R-116R.
46. Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, et al. (1999) Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 274: 9636-9647.
47. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, et al. (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355: 788-798.